Frelick Jeff 4
4 · Bone Biologics Corp · Filed Jan 21, 2025
Insider Transaction Report
Form 4
Frelick Jeff
Chief Executive Officer
Transactions
- Award
Employee Stock Option
2025-01-15+54,110→ 54,110 totalExercise: $0.97From: 2025-01-15Exp: 2027-01-15→ Common Stock (54,110 underlying)
Holdings
- 157
Employee Stock Option
Exercise: $57.60Exp: 2025-01-25→ Common Stock (157 underlying) - 173
Employee Stock Option
Exercise: $9540.00Exp: 2025-12-27→ Common Stock (173 underlying) - 2,151
Common Stock
- 25,000
Employee Stock Option
Exercise: $3.61Exp: 2026-01-17→ Common Stock (25,000 underlying) - 44
Employee Stock Option
Exercise: $12300.00Exp: 2026-05-26→ Common Stock (44 underlying)
Footnotes (2)
- [F1]This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice,vests and becomes exercisable immediately.
- [F2]This option is fully vested as of the date of this report.